241 related articles for article (PubMed ID: 20601196)
1. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in older people: what we know and what we need to know.
Seripa D; Paroni G; Urbano M; Santini SA; D'Onofrio G; Pilotto A
J Nephrol; 2012; 25 Suppl 19():S38-47. PubMed ID: 22476963
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
4. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
Pilotto A; Panza F; Seripa D
Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
[TBL] [Abstract][Full Text] [Related]
7. Measuring pharmacogenetics in special groups: geriatrics.
Seripa D; Panza F; Daragjati J; Paroni G; Pilotto A
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1073-88. PubMed ID: 25990744
[TBL] [Abstract][Full Text] [Related]
8. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
[TBL] [Abstract][Full Text] [Related]
9. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
Ingelman-Sundberg M
Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
[TBL] [Abstract][Full Text] [Related]
11. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives.
Sim SC; Ingelman-Sundberg M
Methods Mol Biol; 2006; 320():183-91. PubMed ID: 16719391
[TBL] [Abstract][Full Text] [Related]
12. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
[TBL] [Abstract][Full Text] [Related]
13. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
Musana AK; Wilke RA
WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
[TBL] [Abstract][Full Text] [Related]
14. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
Duricová J; Grundmann M
Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome p450 part 2: what nurses need to know about the cytochrome p450 family systems.
Krau SD
Nurs Clin North Am; 2013 Dec; 48(4):681-96. PubMed ID: 24295195
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome p450, part 1: what nurses really need to know.
Krau SD
Nurs Clin North Am; 2013 Dec; 48(4):671-80. PubMed ID: 24295194
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
19. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics: towards personalized medicine].
Gurwitz D; Rehavi M
Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
